Electrophysiology Issues and Heart Failure in Congenital Heart Disease

  • Scott R. Ceresnak
  • Anne M. Dubin


There are two major causes of morbidity and mortality in children with heart failure: arrhythmia and pump failure.1, 2, 3, 4 Even in patients receiving treatment for their heart failure, pre-transplant mortality has been shown to be between 12% and 25%, with 25% of deaths secondary to an arrhythmia. The pediatric electrophysiologist can now offer therapies that address both causes of mortality, and potentially improve both quality of life and functional capacity.

Abnormalities in the heart rhythm are a relatively common occurrence in children with heart failure. In the patient with congenital heart disease and heart failure, both atrial and ventricular arrhythmias are frequently seen. These arrhythmias may either result from or lead to further destabilization of the underlying hemodynamic status. Assigning cause and effect can be extremely difficult in this situation.


Congenital Heart Disease Ventricular Tachycardia Cardiac Resynchronization Therapy Atrial Flutter Atrial Arrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Steinberger J, Haines HC, Shumway SJ, Bolman RM, 3rd, Rocchini AP, Braunlin EA. Outcome after referral for pediatric transplantation. J Heart Lung Transplant. 1993;12:766–769.PubMedGoogle Scholar
  2. 2.
    Rosenthal DN, Dubin AM, Chin C, Falco D, Gamberg P, Bernstein D. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Transplant. 2000;19:751–755.PubMedCrossRefGoogle Scholar
  3. 3.
    Nield LE, McCrindle BW, Bohn DJ et al. Outcomes for children with cardiomyopathy awaiting transplantation. Cardiol Young. 2000;10:358–366.PubMedCrossRefGoogle Scholar
  4. 4.
    Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. Prog Pediatr Cardiol. 2000;11:99–105.PubMedCrossRefGoogle Scholar
  5. 5.
    Gillette PC, Yeoman MA, Mullins CE, McNamara DG. Sudden death after repair of tetralogy of Fallot. Electrocardiographic and electrophysiologic abnormalities. Circulation. 1977;56:566–571.PubMedGoogle Scholar
  6. 6.
    Friedman RA, Moak JP, Garson A, Jr. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol. 1991;18:152–156.PubMedCrossRefGoogle Scholar
  7. 7.
    Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975–981.PubMedCrossRefGoogle Scholar
  8. 8.
    Griffin ML, Hernandez A, Martin TC et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. 1988;11:139–144.PubMedCrossRefGoogle Scholar
  9. 9.
    Hayes CJ, Gersony WM. Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study. J Am Coll Cardiol. 1986;7:133–137.PubMedCrossRefGoogle Scholar
  10. 10.
    Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol. 1991;68:365–369.PubMedCrossRefGoogle Scholar
  11. 11.
    Franz MR, Bode F. Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case. Prog Biophys Mol Biol. 2003;82:163–174.PubMedCrossRefGoogle Scholar
  12. 12.
    Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89:724–730.PubMedGoogle Scholar
  13. 13.
    Zeppenfeld K, Schalij MJ, Bartelings MM et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation. 2007;116:2241–2252.PubMedCrossRefGoogle Scholar
  14. 14.
    Sanchez-Quintana D, Climent V, Ho SY, Anderson RH. Myoarchitecture and connective tissue in hearts with tricuspid atresia. Heart. 1999;81:182–191.PubMedGoogle Scholar
  15. 15.
    Dyckner T, Wester PO. Potassium/magnesium depletion in patients with cardiovascular disease. Am J Med. 1987;82:11–17.PubMedCrossRefGoogle Scholar
  16. 16.
    Wiles HB, Gillette PC, Harley RA, Upshur JK. Cardiomyopathy and myocarditis in children with ventricular ectopic rhythm. J Am Coll Cardiol. 1992;20:359–362.PubMedCrossRefGoogle Scholar
  17. 17.
    Samet P, Bernstein WH, Nathan DA, Lopez A. Atrial Contribution to Cardiac Output in Complete Heart Block. Am J Cardiol. 1965;16:1–10.PubMedCrossRefGoogle Scholar
  18. 18.
    Ko JK, Deal BJ, Strasburger JF, Benson DW, Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69:1028–1032.PubMedCrossRefGoogle Scholar
  19. 19.
    Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation. 1993;88:282–295.PubMedGoogle Scholar
  20. 20.
    Fananapazir L, Tracy CM, Leon MB et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation. 1989;80:1259–1268.PubMedGoogle Scholar
  21. 21.
    Vacca JB, Bussmann DW, Mudd JG. Ebstein’s anomaly; complete review of 108 cases. Am J Cardiol. 1958;2:210–226.PubMedCrossRefGoogle Scholar
  22. 22.
    Abrams D, Schilling R. Mechanism and mapping of atrial arrhythmia in the modified Fontan circulation. Heart Rhythm. 2005;2:1138–1144.PubMedCrossRefGoogle Scholar
  23. 23.
    Gillette PC, Kugler JD, Garson A, Jr., Gutgesell HP, Duff DF, McNamara DG. Mechanisms of cardiac arrhythmias after the Mustard operation for transposition of the great arteries. Am J Cardiol. 1980;45:1225–1230.PubMedCrossRefGoogle Scholar
  24. 24.
    Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995;91:2214–2219.PubMedGoogle Scholar
  25. 25.
    Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol. 2007;28:448–456.PubMedCrossRefGoogle Scholar
  26. 26.
    Vetter VL, Tanner CS, Horowitz LN. Electrophysiologic consequences of the Mustard repair of d-transposition of the great arteries. J Am Coll Cardiol. 1987;10:1265–1273.PubMedCrossRefGoogle Scholar
  27. 27.
    Gewillig M, Wyse RK, de Leval MR, Deanfield JE. Early and late arrhythmias after the Fontan operation: predisposing factors and clinical consequences. Br Heart J. 1992;67:72–79.PubMedCrossRefGoogle Scholar
  28. 28.
    Manning PB, Mayer JE, Jr., Wernovsky G, Fishberger SB, Walsh EP. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg. 1996;111:833–839; discussion 839–840.PubMedCrossRefGoogle Scholar
  29. 29.
    Shah MJ, Nehgme R, Carboni M, Murphy JD. Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the fontan procedure. Pacing Clin Electrophysiol. 2004;27:949–954.PubMedCrossRefGoogle Scholar
  30. 30.
    Gelatt M, Hamilton RM, McCrindle BW et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol. 1997;29:194–201.PubMedCrossRefGoogle Scholar
  31. 31.
    Vetter VL, Tanner CS. Electrophysiologic consequences of the arterial switch repair of d-transposition of the great arteries. J Am Coll Cardiol. 1988;12:229–237.PubMedCrossRefGoogle Scholar
  32. 32.
    Packer DL, Bardy GH, Worley SJ et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol. 1986;57:563–570.PubMedCrossRefGoogle Scholar
  33. 33.
    Horenstein MS, Saarel E, Dick M, Karpawich PP. Reversible symptomatic dilated cardiomyopathy in older children and young adolescents due to primary non-sinus supraventricular tachyarrhythmias. Pediatr Cardiol. 2003;24:274–279.PubMedCrossRefGoogle Scholar
  34. 34.
    Walsh EP, Saul JP, Hulse JE et al. Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation. 1992;86:1138–1146.PubMedGoogle Scholar
  35. 35.
    Ozcan C, Jahangir A, Friedman PA et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344:1043–1051.PubMedCrossRefGoogle Scholar
  36. 36.
    Khairy P, Harris L, Landzberg MJ et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117:363–370.PubMedCrossRefGoogle Scholar
  37. 37.
    Minakata K, Dearani JA, O’Leary PW, Danielson GK. Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results. Ann Thorac Surg. 2005;80:1424–1429; discussion 1429–1430.PubMedCrossRefGoogle Scholar
  38. 38.
    Sharma JR, Sathanandam S, Rao SP, Acharya S, Flood V. Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up. Pediatr Cardiol. 2008;29:416–419.PubMedCrossRefGoogle Scholar
  39. 39.
    Hoffman TM, Wernovsky G, Atz AM et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107:996–1002.PubMedCrossRefGoogle Scholar
  40. 40.
    Bossaert L, Van Hoeyweghen R. Bystander cardiopulmonary resuscitation (CPR) in out-of-hospital cardiac arrest. The Cerebral Resuscitation Study Group. Resuscitation. 1989;17(suppl):S55–S69; discussion S199–S206.CrossRefGoogle Scholar
  41. 41.
    Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med. 1989;321:406–412.Google Scholar
  42. 42.
    Fish FA, Gillette PC, Benson DW, Jr. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol. 1991;18:356–365.PubMedCrossRefGoogle Scholar
  43. 43.
    Perry JC, Knilans TK, Marlow D, Denfield SW, Fenrich AL, Friedman RA. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. J Am Coll Cardiol. 1993;22:95–98.PubMedCrossRefGoogle Scholar
  44. 44.
    Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J. 1980;100:1063–1069.PubMedCrossRefGoogle Scholar
  45. 45.
    Friedman RA, Walsh EP, Silka MJ et al. NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol. 2002;25:1000–1017.PubMedCrossRefGoogle Scholar
  46. 46.
    Van Hare GF, Lesh MD, Stanger P. Radiofrequency catheter ablation of supraventricular arrhythmias in patients with congenital heart disease: results and technical considerations. J Am Coll Cardiol. 1993;22:883–890.PubMedCrossRefGoogle Scholar
  47. 47.
    Morwood JG, Triedman JK, Berul CI et al. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004;1:301–308.PubMedCrossRefGoogle Scholar
  48. 48.
    Thornton AS, Janse P, Alings M et al. Acute success and short-term follow-up of catheter ablation of isthmus-dependent atrial flutter; a comparison of 8 mm tip radiofrequency and cryothermy catheters. J Interv Card Electrophysiol. 2008;21:241–248.PubMedCrossRefGoogle Scholar
  49. 49.
    Triedman JK, Bergau DM, Saul JP, Epstein MR, Walsh EP. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997;30:1032–1038.PubMedCrossRefGoogle Scholar
  50. 50.
    Kanter RJ, Papagiannis J, Carboni MP, Ungerleider RM, Sanders WE, Wharton JM. Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries. J Am Coll Cardiol. 2000;35:428–441.PubMedCrossRefGoogle Scholar
  51. 51.
    Van Hare GF, Lesh MD, Ross BA, Perry JC, Dorostkar PC. Mapping and radiofrequency ablation of intraatrial reentrant tachycardia after the Senning or Mustard procedure for transposition ofthe great arteries. Am J Cardiol. 1996;77:985–991.PubMedCrossRefGoogle Scholar
  52. 52.
    Misaki T, Tsubota M, Watanabe G et al. Surgical treatment of ventricular tachycardia after surgical repair of tetralogy of Fallot. Relation between intraoperative mapping and histological findings. Circulation. 1994;90:264–271.PubMedGoogle Scholar
  53. 53.
    Triedman JK, Jenkins KJ, Colan SD, Saul JP, Walsh EP. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997;8:259–270.PubMedCrossRefGoogle Scholar
  54. 54.
    Triedman JK, Saul JP, Weindling SN, Walsh EP. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation. 1995;91:707–714.PubMedGoogle Scholar
  55. 55.
    Mavroudis C, Backer CL, Deal BJ, Johnsrude CL. Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoblation. J Thorac Cardiovasc Surg. 1998;115:547–556.PubMedCrossRefGoogle Scholar
  56. 56.
    Zahka KG, Horneffer PJ, Rowe SA et al. Long-term valvular function after total repair of tetralogy of Fallot. Relation to ventricular arrhythmias. Circulation. 1988;78:III14–III19.PubMedGoogle Scholar
  57. 57.
    Therrien J, Siu SC, Harris L et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001;103:2489–2494.PubMedGoogle Scholar
  58. 58.
    A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337:1576–1583.Google Scholar
  59. 59.
    Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237.PubMedCrossRefGoogle Scholar
  60. 60.
    Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol. 1996;77:524–526.PubMedCrossRefGoogle Scholar
  61. 61.
    Dubin AM, Berul CI, Bevilacqua LM et al. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. J Card Fail. 2003;9:375–379.PubMedCrossRefGoogle Scholar
  62. 62.
    Silka MJ, Kron J, Dunnigan A, Dick M, 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation. 1993;87:800–807.PubMedGoogle Scholar
  63. 63.
    Berul CI, Van Hare GF, Kertesz NJ et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–1691.PubMedCrossRefGoogle Scholar
  64. 64.
    Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004;15:72–76.PubMedCrossRefGoogle Scholar
  65. 65.
    Sandner SE, Wieselthaler G, Zuckermann A et al. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation. 2001;104:I171–I176.PubMedCrossRefGoogle Scholar
  66. 66.
    Schmidinger H. The implantable cardioverter defibrillator as a “bridge to transplant”: a viable clinical strategy? Am J Cardiol. 1999;83:151D–157D.PubMedCrossRefGoogle Scholar
  67. 67.
    Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32:245–251.PubMedCrossRefGoogle Scholar
  68. 68.
    Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231–237.PubMedGoogle Scholar
  69. 69.
    Chandar JS, Wolff GS, Garson A, Jr. et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol. 1990;65:655–661.PubMedCrossRefGoogle Scholar
  70. 70.
    Harrison DA, Harris L, Siu SC et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol. 1997;30:1368–1373.PubMedCrossRefGoogle Scholar
  71. 71.
    Hokanson JS, Moller JH. Significance of early transient complete heart block as a predictor of sudden death late after operative correction of tetralogy of Fallot. Am J Cardiol. 2001;87:1271–1277.PubMedCrossRefGoogle Scholar
  72. 72.
    Khairy P, Landzberg MJ, Gatzoulis MA et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004;109:1994–2000.PubMedCrossRefGoogle Scholar
  73. 73.
    Sarkar D, Bull C, Yates R et al. Comparison of long-term outcomes of atrial repair of simple transposition with implications for a late arterial switch strategy. Circulation. 1999;100:II176–II181.PubMedGoogle Scholar
  74. 74.
    Puley G, Siu S, Connelly M et al. Arrhythmia and survival in patients >18 years of age after the mustard procedure for complete transposition of the great arteries. Am J Cardiol. 1999;83:1080–1084.PubMedCrossRefGoogle Scholar
  75. 75.
    Dos L, Teruel L, Ferreira IJ et al. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart. 2005;91:652–656.PubMedCrossRefGoogle Scholar
  76. 76.
    Kammeraad JA, van Deurzen CH, Sreeram N et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004;44:1095–1102.PubMedCrossRefGoogle Scholar
  77. 77.
    Link MS, Hill SL, Cliff DL et al. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol. 1999;83:263–266, A5–A6.PubMedCrossRefGoogle Scholar
  78. 78.
    Klug D, Vaksmann G, Jarwe M et al. Pacemaker lead infection in young patients. Pacing Clin Electrophysiol. 2003;26:1489–1493.PubMedCrossRefGoogle Scholar
  79. 79.
    Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150–159.PubMedCrossRefGoogle Scholar
  80. 80.
    Grimm W, Menz V, Hoffmann J et al. Complications of third-generation implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol. 1999;22:206–211.PubMedCrossRefGoogle Scholar
  81. 81.
    Figa FH, McCrindle BW, Bigras JL, Hamilton RM, Gow RM. Risk factors for venous obstruction in children with transvenous pacing leads. Pacing Clin Electrophysiol. 1997;20:1902–1909.PubMedCrossRefGoogle Scholar
  82. 82.
    Bar-Cohen Y, Berul CI, Alexander ME et al. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol. 2006;17:754–759.PubMedCrossRefGoogle Scholar
  83. 83.
    Stephenson EA, Batra AS, Knilans TK et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006;17:41–46.PubMedCrossRefGoogle Scholar
  84. 84.
    Bauersfeld U, Tomaske M, Dodge-Khatami A, Rahn M, Kellenberger CJ, Pretre R. Initial experience with implantable cardioverter defibrillator systems using epicardial and pleural electrodes in pediatric patients. Ann Thorac Surg. 2007;84:303–305.PubMedCrossRefGoogle Scholar
  85. 85.
    Kriebel T, Ruschewski W, Gonzalez y Gonzalez M et al. ICD Implantation in infants and small children: the extracardiac technique. Pacing Clin Electrophysiol. 2006;29:1319–1325.PubMedCrossRefGoogle Scholar
  86. 86.
    Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation. 1989;79:845–853.PubMedGoogle Scholar
  87. 87.
    Duncan AM, Francis DP, Gibson DG, Henein MY. Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle-branch block and coronary artery disease. J Am Coll Cardiol. 2004;43:1524–1531.PubMedCrossRefGoogle Scholar
  88. 88.
    Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853.PubMedCrossRefGoogle Scholar
  89. 89.
    Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.PubMedCrossRefGoogle Scholar
  90. 90.
    Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–880.PubMedCrossRefGoogle Scholar
  91. 91.
    Epstein AE, Dimarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm. 2008;5:e1–e62.PubMedCrossRefGoogle Scholar
  92. 92.
    Alexander ME, Berul CI, Fortescue EB et al. Who is eligible for cardiac resyncrhonizationtherapy in pediatric cardiology? Heart Rhythm. 2004;1:S122.Google Scholar
  93. 93.
    Janousek J, Tomek V, Chaloupecky VA et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol. 2004;44:1927–1931.PubMedCrossRefGoogle Scholar
  94. 94.
    Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003;107:2287–2289.PubMedCrossRefGoogle Scholar
  95. 95.
    Strieper M, Karpawich P, Frias P et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol. 2004;94:1352–1354.PubMedCrossRefGoogle Scholar
  96. 96.
    Bacha EA, Zimmerman FJ, Mor-Avi V et al. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann Thorac Surg. 2004;78:1678–1683.PubMedCrossRefGoogle Scholar
  97. 97.
    Zimmerman FJ, Starr JP, Koenig PR, Smith P, Hijazi ZM, Bacha EA. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg. 2003;75:1775–1780.PubMedCrossRefGoogle Scholar
  98. 98.
    Cecchin F, Frangini PA, Brown DW et al. Cardiac Resynchronization Therapy (and Multisite Pacing) in Pediatrics and Congenital Heart Disease: Five Years Experience in a Single Institution. J Cardiovasc Electrophysiol. 2008;58–65.Google Scholar
  99. 99.
    Dubin AM, Janousek J, Rhee E et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277–2283.PubMedCrossRefGoogle Scholar

Copyright information

© Springer London 2010

Authors and Affiliations

  • Scott R. Ceresnak
    • 1
  • Anne M. Dubin
    • 1
  1. 1.Lucile Packard Children’s HospitalStanford University School of MedicinePalo AltoUS

Personalised recommendations